|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-OPC-16008702 |
|
Date of registration:
|
2016-06-22 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Efficacy and safety of oral sildenafil in the treatment of pediatric lymphatic malformations in China
|
|
Scientific title:
|
Sildenafil in the treatment of pediatric lymphatic malformations |
|
Date of first enrolment:
|
2014-05-01 |
|
Target sample size:
|
Sildenafil-treated group:40; |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=14688 |
|
Study type:
|
Observational study |
|
Study design:
|
Case series
|
|
Phase:
|
Pilot study
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Xin Ni
|
|
Address:
|
56 South Lishi Road, Xicheng District, Beijing
|
|
Telephone:
|
+86 010 59616393 |
|
Email:
|
Nixin@bch.com.cn |
|
Affiliation:
|
Beijing Children's Hospital |
|
|
Name:
|
Shengcai Wang
|
|
Address:
|
56 South Lishi Road, Xicheng District, Beijing
|
|
Telephone:
|
+86 010 59616391 |
|
Email:
|
wsc820329@163.com |
|
Affiliation:
|
Beijing Children's Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: under 9 years old, diagnosed of LMs based on clinical and radiographic criteria with lesions located at any part of the body, had indications for treatment and guardians desired for therapy.
Exclusion criteria: Patients with hypertension, heart problems, renal diseases, life-threatening airway obstruction or allergy to sildenafil were excluded from the study
Age minimum:
Age maximum:
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
pediatric lymphatic malformations
|
|
Intervention(s)
|
|
Sildenafil-treated group:oral sildenafil;
|
|
Primary Outcome(s)
|
|
MRI images;
|
|
Source(s) of Monetary Support
|
|
This study was supported by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, code: ZYLX201508.
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|